BTG International Limited (2006) Structured phospholipids. WO2006/056783 A2.

Preview

PDF WO2006056783A2.pdf Download (2MB)

Abstract

A method of treating a patient in need of therapy for a disease in which cyokines have become dysregulated, or are otherwise capable of modulation to provide therapeutic benefit, is provided comprising administering to that patient a therapeutically effective dose of a phospholipid comprising a phosphatidyl group esterifed with one or more fatty acyl groups, characterised in that the phospholipid has at least one fatty acyl group at the sn-1 and/or sn-2 position of the phosphatidyl group, the fatty acyl group being selected from the group consisting of ?-linolenoyl, dihomo-?-linolenoyl acid and arachidonoyl.

Item Type:	Patent
Additional Information:	Publication date: Jun 1, 2006 Publication number: WO_2006_056783_A2 Application date: Nov 25, 2005 Application number: GB_2005004516_W
Uncontrolled Keywords:	phospholipids, treatment of multiple sclerosis
Subjects:	Q Science > QD Chemistry R Medicine > RM Therapeutics. Pharmacology
Faculty / School / Research Centre / Research Group:	Faculty of Education, Health & Human Sciences > School of Human Sciences (HUM)
Related URLs:	Organisation
Last Modified:	09 Oct 2021 04:46
URI:	http://gala.gre.ac.uk/id/eprint/4327

Actions (login required)

View Item

Downloads